Amneal Pharmaceuticals (AMRX) Notes Payables (2018 - 2024)
Historic Notes Payables for Amneal Pharmaceuticals (AMRX) over the last 5 years, with Q1 2024 value amounting to $41.9 million.
- Amneal Pharmaceuticals' Notes Payables changed N/A to $41.9 million in Q1 2024 from the same period last year, while for Mar 2024 it was $41.9 million, marking a year-over-year change of. This contributed to the annual value of $41.4 million for FY2023, which is 438.47% up from last year.
- As of Q1 2024, Amneal Pharmaceuticals' Notes Payables stood at $41.9 million.
- Amneal Pharmaceuticals' 5-year Notes Payables high stood at $41.9 million for Q1 2024, and its period low was $1.0 million during Q1 2020.
- Over the past 4 years, Amneal Pharmaceuticals' median Notes Payables value was $39.7 million (recorded in 2022), while the average stood at $23.2 million.
- Examining YoY changes over the last 5 years, Amneal Pharmaceuticals' Notes Payables showed a top increase of 438.47% in 2023 and a maximum decrease of 438.47% in 2023.
- Over the past 4 years, Amneal Pharmaceuticals' Notes Payables (Quarter) stood at $1.0 million in 2020, then skyrocketed by 3870.6% to $39.7 million in 2022, then increased by 4.38% to $41.4 million in 2023, then grew by 1.08% to $41.9 million in 2024.
- Its Notes Payables stands at $41.9 million for Q1 2024, versus $41.4 million for Q4 2023 and $41.0 million for Q3 2023.